Moderna Says FDA Approved sBLAs For 2026-2027 Spikevax And mNEXSPIKE Formulas Targeting JN.1-Lineage XFG Subvariant; Says Vaccines Expected Available In Coming Days

Benzinga Newsdesk www.benzinga.com Positive 74.4%

Neg 0% Neu 0% Pos 74.4%

Comments

No comments yet. Be the first!